CVS 2010 Annual Report Download - page 6

Download and view the complete annual report

Please find page 6 of the 2010 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 82

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82

Generic drug substitution means good news for
patients, health plan sponsors…and our bottom line.
Since generic prescriptions cost far less than their brand-name counterparts,
they play an important role in controlling costs for health plans, their members,
and the uninsured. By 2012, an effective generic alternative will be available
in every critical class of drugs. Our retail Customer Savings Initiative and PBM
generic step therapies are just two ways in which CVS Caremark helps patients
make the switch. In addition to providing major savings for payors and
patients, generic drugs also provide significantly higher margins for pharmacy
providers. As the nation’s largest purchaser of pharmaceuticals, CVS Caremark
is well-positioned to benefit as approximately $90 billion in branded drugs are
expected to lose patent protection over the next five years.
is this
A $10 Generic Prescription
- or -
Billions of Dollars in Cost Savings
?
– 2 –
CVS Caremark 2010 Annual Report